HUMAN IMMUNOGLOBULIN G

HUMAN IMMUNOGLOBULIN G was reported 20933 times

These side effects are most commonly reported by patients taking HUMAN IMMUNOGLOBULIN G:

# Side effect Count
0 OFF LABEL USE 4507
1 DRUG INEFFECTIVE 2572
2 FATIGUE 2502
3 HEADACHE 2311
4 COVID-19 2175
5 PNEUMONIA 1924
6 SINUSITIS 1900
7 PRODUCT DOSE OMISSION ISSUE 1870
8 NAUSEA 1634
9 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1589
10 MALAISE 1535
11 PYREXIA 1514
12 FALL 1375
13 PAIN 1308
14 DYSPNOEA 1246
15 ILLNESS 1228
16 INFECTION 1208
17 DIARRHOEA 1155
18 URINARY TRACT INFECTION 1155
19 NASOPHARYNGITIS 1109
20 COUGH 1087
21 VOMITING 1019
22 DIZZINESS 994
23 DEATH 967
24 ASTHENIA 948
25 ARTHRALGIA 942
26 BLOOD PRESSURE INCREASED 909
27 INSURANCE ISSUE 909
28 WEIGHT DECREASED 891
29 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 885
30 CHILLS 860
31 PRODUCT USE ISSUE 857
32 INFUSION RELATED REACTION 830
33 CONDITION AGGRAVATED 816
34 BRONCHITIS 789
35 PRODUCT USE IN UNAPPROVED INDICATION 779
36 INFLUENZA 776
37 PRURITUS 747
38 UPPER RESPIRATORY TRACT INFECTION 694
39 INFUSION SITE PAIN 693
40 SEPSIS 677
41 BACK PAIN 674
42 RASH 661
43 ABDOMINAL PAIN 614
44 PAIN IN EXTREMITY 597
45 DRUG HYPERSENSITIVITY 552
46 WEIGHT INCREASED 542
47 INFUSION SITE SWELLING 538
48 ASTHMA 523
49 MIGRAINE 515
50 RESPIRATORY TRACT INFECTION 513
51 SOMNOLENCE 505
52 TACHYCARDIA 504
53 INFUSION SITE ERYTHEMA 501
54 EAR INFECTION 484
55 FEELING ABNORMAL 479
56 SEASONAL ALLERGY 475
57 HYPERTENSION 471
58 THERAPY NON-RESPONDER 470
59 ARTHRITIS 466
60 MYALGIA 458
61 MULTIPLE ALLERGIES 453
62 VIRAL INFECTION 444
63 CONTUSION 436
64 GASTROINTESTINAL DISORDER 430
65 INSOMNIA 427
66 ABDOMINAL PAIN UPPER 400
67 DECREASED APPETITE 397
68 OROPHARYNGEAL PAIN 383
69 URTICARIA 381
70 POOR VENOUS ACCESS 380
71 HYPERSENSITIVITY 379
72 DRUG INTOLERANCE 376
73 GASTROENTERITIS VIRAL 370
74 HYPOTENSION 369
75 PERIPHERAL SWELLING 366
76 INCORRECT DOSE ADMINISTERED 363
77 ANXIETY 361
78 INCORRECT DRUG ADMINISTRATION RATE 359
79 INTENTIONAL PRODUCT USE ISSUE 359
80 MUSCULAR WEAKNESS 355
81 CHEST PAIN 342
82 ABDOMINAL DISCOMFORT 341
83 ERYTHEMA 341
84 LOSS OF CONSCIOUSNESS 340
85 INFUSION SITE BRUISING 336
86 INFUSION SITE PRURITUS 335
87 INFUSION SITE HAEMORRHAGE 327
88 TREATMENT FAILURE 327
89 LOWER RESPIRATORY TRACT INFECTION 324
90 CHEST DISCOMFORT 318
91 GAIT DISTURBANCE 316
92 ANAEMIA 312
93 SYNCOPE 311
94 PLATELET COUNT DECREASED 309
95 MATERNAL EXPOSURE DURING PREGNANCY 307
96 FOETAL EXPOSURE DURING PREGNANCY 298
97 SWELLING 297
98 SEPTIC SHOCK 296
99 DERMATITIS CONTACT 294
100 RHEUMATOID ARTHRITIS 292
101 VISION BLURRED 286
102 INFUSION SITE DISCHARGE 285
103 EYE PAIN 282
104 CATARACT 275
105 CELLULITIS 274
106 ABDOMINAL DISTENSION 272
107 PRODUCTIVE COUGH 270
108 COMA 269
109 TREMOR 268
110 BLOOD PRESSURE DECREASED 267
111 DIPLOPIA 267
112 HERPES ZOSTER 265
113 THROMBOCYTOPENIA 264
114 MUSCLE SPASMS 263
115 SINUS DISORDER 263
116 ARTHROPATHY 262
117 BLOOD IMMUNOGLOBULIN G DECREASED 262
118 HEAD DISCOMFORT 262
119 NEOPLASM MALIGNANT 260
120 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 259
121 PULMONARY EMBOLISM 256
122 INFLUENZA LIKE ILLNESS 255
123 DEHYDRATION 254
124 HEART RATE INCREASED 253
125 THROMBOSIS 253
126 NO ADVERSE EVENT 252
127 RESPIRATORY FAILURE 252
128 SEIZURE 252
129 BLINDNESS 249
130 CONSTIPATION 249
131 FUNGAL INFECTION 249
132 HYPOAESTHESIA 249
133 NEUROPATHY PERIPHERAL 248
134 OCULAR DISCOMFORT 244
135 SYSTEMIC LUPUS ERYTHEMATOSUS 241
136 ASCITES 240
137 TINNITUS 240
138 ALTERED STATE OF CONSCIOUSNESS 237
139 CYSTITIS 237
140 HAEMATEMESIS 232
141 LIMB INJURY 231
142 PSORIASIS 230
143 THERAPEUTIC PRODUCT EFFECT DECREASED 230
144 LOCALISED INFECTION 229
145 MEMORY IMPAIRMENT 229
146 NEEDLE ISSUE 229
147 OXYGEN SATURATION DECREASED 229
148 ADRENAL INSUFFICIENCY 228
149 HAEMATURIA 226
150 HAEMORRHAGIC STROKE 225
151 HYPOKALAEMIA 225
152 KIDNEY INFECTION 225
153 INJECTION SITE PAIN 224
154 PARAESTHESIA 223
155 CARDIO-RESPIRATORY ARREST 221
156 MOBILITY DECREASED 221
157 LUNG DISORDER 219
158 WHEEZING 219
159 MENINGITIS ASEPTIC 218
160 IMMUNODEFICIENCY 216
161 STRESS 216
162 HOSPITALISATION 215
163 PHOTOPHOBIA 214
164 PRODUCT DISTRIBUTION ISSUE 213
165 AMAUROSIS FUGAX 212
166 ANAPHYLACTIC REACTION 212
167 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 212
168 NEUTROPENIA 212
169 PRESYNCOPE 211
170 DEVICE INFUSION ISSUE 210
171 GENERALISED OEDEMA 208
172 NEPHROLITHIASIS 207
173 PLEURAL EFFUSION 207
174 DISEASE PROGRESSION 205
175 MUSCULOSKELETAL STIFFNESS 201
176 STAPHYLOCOCCAL INFECTION 201
177 THERAPY INTERRUPTED 200
178 JOINT INJURY 198
179 OEDEMA 197
180 NASAL CONGESTION 195
181 POLYARTHRITIS 195
182 RHINORRHOEA 195
183 URINARY TRACT DISORDER 195
184 CEREBROVASCULAR ACCIDENT 194
185 NECK PAIN 193
186 CARDIAC DISORDER 192
187 ATRIAL FIBRILLATION 191
188 DRUG INTERACTION 191
189 HAEMOGLOBIN DECREASED 191
190 WHITE BLOOD CELL COUNT DECREASED 190
191 ALOPECIA 189
192 MYASTHENIA GRAVIS 189
193 GASTROOESOPHAGEAL REFLUX DISEASE 187
194 INFUSION SITE EXTRAVASATION 187
195 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 186
196 INFUSION SITE MASS 185
197 COVID-19 PNEUMONIA 183
198 LIMB DISCOMFORT 183
199 MULTIPLE ORGAN DYSFUNCTION SYNDROME 183
200 EXPOSURE DURING PREGNANCY 181
201 DYSPHAGIA 180
202 GENERAL PHYSICAL HEALTH DETERIORATION 178
203 TOOTH INFECTION 177
204 RENAL FAILURE 176
205 JOINT SWELLING 175
206 HAEMORRHAGE 171
207 DEEP VEIN THROMBOSIS 170
208 ACUTE KIDNEY INJURY 168
209 DEPRESSION 168
210 EPISTAXIS 168
211 HYPOXIA 168
212 INJECTION SITE ERYTHEMA 168
213 DIABETES MELLITUS 167
214 OBESITY 167
215 FIBROMYALGIA 166
216 SKIN INFECTION 166
217 CANDIDA INFECTION 165
218 PHARYNGITIS STREPTOCOCCAL 164
219 PRODUCT AVAILABILITY ISSUE 164
220 LYMPHADENOPATHY 163
221 ROAD TRAFFIC ACCIDENT 163
222 FLUSHING 161
223 BACTERIAL INFECTION 158
224 MYOCARDIAL INFARCTION 158
225 INJECTION SITE SWELLING 155
226 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 154
227 RESPIRATORY SYNCYTIAL VIRUS INFECTION 154
228 PANCYTOPENIA 152
229 SKIN LACERATION 152
230 SYNOVITIS 152
231 CONFUSIONAL STATE 151
232 HAEMOLYTIC ANAEMIA 151
233 HYPOCALCAEMIA 151
234 CONTRAINDICATED PRODUCT ADMINISTERED 150
235 DIVERTICULITIS 150
236 BLOOD PRESSURE ABNORMAL 149
237 PREGNANCY 149
238 PULMONARY FIBROSIS 149
239 OSTEOPOROSIS 147
240 PALPITATIONS 146
241 VISUAL IMPAIRMENT 146
242 HEPATIC ENZYME INCREASED 145
243 JOINT DESTRUCTION 145
244 CYTOMEGALOVIRUS INFECTION 144
245 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 143
246 HYPERHIDROSIS 141
247 FOOT FRACTURE 140
248 CLOSTRIDIUM DIFFICILE INFECTION 138
249 C-REACTIVE PROTEIN INCREASED 137
250 AUTOIMMUNE DISORDER 136
251 BRAIN FOG 136
252 INFLAMMATION 135
253 WEIGHT FLUCTUATION 134
254 RENAL IMPAIRMENT 133
255 INTERSTITIAL LUNG DISEASE 132
256 OEDEMA PERIPHERAL 132
257 POST PROCEDURAL COMPLICATION 132
258 VERTIGO 132
259 EYE INFECTION 130
260 HEAD INJURY 130
261 IMMUNOGLOBULINS DECREASED 130
262 BALANCE DISORDER 129
263 IMMUNE THROMBOCYTOPENIA 129
264 DYSPHONIA 128
265 BRONCHIECTASIS 127
266 LEUKOPENIA 127
267 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 125
268 DEVICE ISSUE 125
269 GASTROINTESTINAL INFECTION 124
270 INFUSION SITE REACTION 124
271 PNEUMONIA BACTERIAL 124
272 INCORRECT PRODUCT ADMINISTRATION DURATION 123
273 DRUG TOLERANCE 121
274 RENAL DISORDER 121
275 UNDERDOSE 121
276 RASH PRURITIC 120
277 BODY TEMPERATURE INCREASED 119
278 LETHARGY 118
279 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 117
280 ILL-DEFINED DISORDER 116
281 OBSTRUCTION 116
282 RESPIRATORY DISORDER 115
283 INABILITY TO AFFORD MEDICATION 114
284 HIP FRACTURE 113
285 PSEUDOMONAS INFECTION 113
286 PREMATURE BABY 112
287 SCAR 111
288 SINUS CONGESTION 111
289 COLITIS 110
290 MUSCULOSKELETAL DISCOMFORT 110
291 THROAT IRRITATION 108
292 BLISTER 107
293 INJECTION SITE BRUISING 107
294 PROCEDURAL PAIN 107
295 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 104
296 RHEUMATOID FACTOR POSITIVE 104
297 WHEELCHAIR USER 104
298 ABORTION SPONTANEOUS 103
299 FEBRILE NEUTROPENIA 103
300 CARDIAC ARREST 102
301 INFUSION SITE DISCOMFORT 102
302 INJECTION SITE PRURITUS 102
303 RIB FRACTURE 102
304 TRANSPLANT REJECTION 102
305 ECZEMA 101
306 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 101
307 THERAPY PARTIAL RESPONDER 101
308 FLUID RETENTION 100
309 ASPERGILLUS INFECTION 99
310 HAEMOLYSIS 99
311 NODULE 99
312 SLEEP DISORDER 99
313 ADVERSE DRUG REACTION 98
314 DRY MOUTH 98
315 DYSPEPSIA 98
316 NEURALGIA 98
317 DISCOMFORT 97
318 EAR PAIN 96
319 GASTROINTESTINAL HAEMORRHAGE 96
320 HEART RATE DECREASED 96
321 PEMPHIGUS 96
322 PNEUMONIA ASPIRATION 96
323 SWELLING FACE 96
324 BLOOD IRON DECREASED 94
325 TACHYPNOEA 94
326 TENDERNESS 94
327 CHRONIC SINUSITIS 93
328 EPSTEIN-BARR VIRUS INFECTION 93
329 HYPOGAMMAGLOBULINAEMIA 93
330 ARTHROPOD BITE 92
331 CARDIAC FAILURE 92
332 CONJUNCTIVITIS 92
333 TRANSIENT ISCHAEMIC ATTACK 92
334 GLOSSODYNIA 91
335 RED BLOOD CELL SEDIMENTATION RATE INCREASED 91
336 SPEECH DISORDER 91
337 CARDIAC FAILURE CONGESTIVE 90
338 FOOT DEFORMITY 90
339 TREATMENT NONCOMPLIANCE 90
340 HAND DEFORMITY 89
341 HERNIA 89
342 LYMPHOMA 89
343 GAIT INABILITY 88
344 NEUTROPHIL COUNT DECREASED 87
345 PHARYNGITIS 87
346 PRODUCT DOSE OMISSION IN ERROR 87
347 SNEEZING 87
348 CYTOMEGALOVIRUS VIRAEMIA 85
349 DEPRESSED MOOD 85
350 FEELING COLD 85
351 MENTAL DISORDER 85
352 OSTEOMYELITIS 85
353 BACK DISORDER 84
354 DRY SKIN 84
355 FEELING HOT 84
356 POST PROCEDURAL INFECTION 84
357 SKIN CANCER 84
358 SPINAL FRACTURE 84
359 WOUND 84
360 BONE DENSITY DECREASED 83
361 FOOD ALLERGY 83
362 HYPERSOMNIA 83
363 INFUSION SITE RASH 83
364 BURNING SENSATION 82
365 RESPIRATORY TRACT CONGESTION 82
366 CYTOKINE RELEASE SYNDROME 81
367 PLASMA CELL MYELOMA 81
368 BREAST CANCER 80
369 LIVER DISORDER 80
370 BLOOD CREATININE INCREASED 79
371 RESPIRATORY DISTRESS 79
372 STREPTOCOCCAL INFECTION 79
373 THROMBOTIC MICROANGIOPATHY 79
374 TOOTH ABSCESS 79
375 UPPER LIMB FRACTURE 79
376 INJECTION SITE HAEMORRHAGE 78
377 INSPIRATORY CAPACITY DECREASED 78
378 IRRITABLE BOWEL SYNDROME 78
379 POOR QUALITY SLEEP 78
380 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 78
381 DISEASE RECURRENCE 77
382 ESCHERICHIA INFECTION 76
383 HEPATOTOXICITY 76
384 SKIN DISORDER 76
385 WHITE BLOOD CELL COUNT INCREASED 76
386 BLOOD GLUCOSE INCREASED 75
387 LOWER LIMB FRACTURE 75
388 PRODUCT STORAGE ERROR 75
389 RASH MACULAR 75
390 VASCULAR DEVICE INFECTION 75
391 CYTOMEGALOVIRUS INFECTION REACTIVATION 74
392 MUSCULOSKELETAL PAIN 74
393 ANTIBODY TEST POSITIVE 73
394 BRADYCARDIA 73
395 LARYNGITIS 73
396 PNEUMOCYSTIS JIROVECII PNEUMONIA 73
397 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 73
398 INJECTION SITE MASS 72
399 LIGAMENT SPRAIN 72
400 MENINGITIS 72
401 PANCREATITIS 72
402 SCIATICA 72
403 SPLENOMEGALY 72
404 DYSPNOEA EXERTIONAL 71
405 INFUSION SITE URTICARIA 71
406 OSTEOARTHRITIS 71
407 PSORIATIC ARTHROPATHY 71
408 PULMONARY MASS 71
409 THYROID DISORDER 71
410 BLOOD IMMUNOGLOBULIN G INCREASED 70
411 BONE PAIN 70
412 FOOD POISONING 70
413 JUVENILE IDIOPATHIC ARTHRITIS 70
414 COAGULOPATHY 69
415 POST-ACUTE COVID-19 SYNDROME 69
416 POSTOPERATIVE WOUND INFECTION 69
417 DRUG RESISTANCE 68
418 GASTRIC ULCER 68
419 INFUSION SITE IRRITATION 68
420 ANGIOEDEMA 67
421 BLOOD IMMUNOGLOBULIN A DECREASED 67
422 CYTOPENIA 67
423 IMPAIRED GASTRIC EMPTYING 67
424 IMPAIRED HEALING 67
425 MYELOSUPPRESSION 67
426 C-REACTIVE PROTEIN ABNORMAL 66
427 MASS 66
428 NERVOUS SYSTEM DISORDER 66
429 PRODUCT USE COMPLAINT 66
430 COGNITIVE DISORDER 65
431 INFUSION SITE SCAR 65
432 LEUKAEMIA 65
433 PRODUCT PRESCRIBING ISSUE 65
434 THERAPEUTIC RESPONSE SHORTENED 65
435 DYSARTHRIA 64
436 FOETAL GROWTH RESTRICTION 64
437 RHINITIS 64
438 TOOTH DISORDER 64
439 BLOOD IMMUNOGLOBULIN M DECREASED 63
440 BLOOD SODIUM DECREASED 63
441 HAEMATOMA 63
442 IMMUNE-MEDIATED MYOSITIS 63
443 TOXIC EPIDERMAL NECROLYSIS 63
444 WOUND INFECTION 63
445 CONCUSSION 62
446 HAEMATOCHEZIA 62
447 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 62
448 DERMATOMYOSITIS 61
449 EYE DISORDER 61
450 LIQUID PRODUCT PHYSICAL ISSUE 61
451 OBSTRUCTIVE AIRWAYS DISORDER 61
452 ORAL CANDIDIASIS 61
453 ORAL HERPES 61
454 PREMATURE DELIVERY 61
455 PULMONARY THROMBOSIS 61
456 ROTATOR CUFF SYNDROME 61
457 ARRHYTHMIA 60
458 BODY HEIGHT BELOW NORMAL 60
459 LYMPHOCYTE COUNT DECREASED 60
460 NERVOUSNESS 60
461 PRODUCT SUPPLY ISSUE 60
462 RASH ERYTHEMATOUS 60
463 RESPIRATORY RATE INCREASED 60
464 SKIN DISCOLOURATION 60
465 SKIN ULCER 60
466 ALANINE AMINOTRANSFERASE INCREASED 59
467 BLOOD TEST ABNORMAL 59
468 BODY HEIGHT DECREASED 59
469 EYELID PTOSIS 59
470 INTESTINAL OBSTRUCTION 59
471 ASPARTATE AMINOTRANSFERASE INCREASED 58
472 BACK INJURY 58
473 HYPERVOLAEMIA 58
474 IMMUNISATION REACTION 58
475 JOINT STIFFNESS 58
476 NOROVIRUS INFECTION 58
477 PRODUCT QUALITY ISSUE 58
478 RHINOVIRUS INFECTION 58
479 SKIN ABRASION 58
480 STOMATITIS 58
481 THROAT TIGHTNESS 58
482 WRIST FRACTURE 58
483 IRRITABILITY 57
484 PRODUCT ADMINISTRATION ERROR 57
485 BLOOD CREATINE PHOSPHOKINASE INCREASED 56
486 DRY EYE 56
487 TOXICITY TO VARIOUS AGENTS 56
488 BACTERAEMIA 55
489 BLOOD POTASSIUM DECREASED 55
490 ENCEPHALITIS 55
491 HELICOBACTER INFECTION 55
492 INJURY 55
493 MULTIPLE-DRUG RESISTANCE 55
494 MUSCLE STRAIN 55
495 PANIC ATTACK 55
496 PERICARDIAL EFFUSION 55
497 SLEEP APNOEA SYNDROME 55
498 WALKING AID USER 55
499 EPILEPSY 54
500 FULL BLOOD COUNT ABNORMAL 54
501 HAEMOPTYSIS 54
502 LYME DISEASE 54
503 SHOCK 54
504 SKIN LESION 54
505 UPPER-AIRWAY COUGH SYNDROME 54
506 AGITATION 53
507 AUTOIMMUNE HAEMOLYTIC ANAEMIA 53
508 HOT FLUSH 53
509 JOINT EFFUSION 53
510 LIVER FUNCTION TEST ABNORMAL 53
511 MOVEMENT DISORDER 53
512 PARAESTHESIA ORAL 53
513 RESPIRATORY TRACT INFECTION VIRAL 53
514 SJOGREN^S SYNDROME 53
515 BLOOD PRESSURE FLUCTUATION 52
516 BURSITIS 52
517 CYST 52
518 DEVICE LEAKAGE 52
519 FOOT OPERATION 52
520 GUILLAIN-BARRE SYNDROME 52
521 PALLOR 52
522 PRESCRIBED UNDERDOSE 52
523 SENSITIVE SKIN 52
524 SKIN EXFOLIATION 52
525 SURGERY 52
526 SYRINGE ISSUE 52
527 ULCER 52
528 AMNESIA 51
529 BLOOD MAGNESIUM DECREASED 51
530 CROHN^S DISEASE 51
531 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 51
532 VEIN DISORDER 51
533 ACUTE RESPIRATORY FAILURE 50
534 ALLERGY TO IMMUNOGLOBULIN THERAPY 50
535 ATAXIA 50
536 DELIRIUM 50
537 INTERVERTEBRAL DISC PROTRUSION 50
538 PNEUMOTHORAX 50
539 QUALITY OF LIFE DECREASED 50
540 SUSPECTED OFF LABEL USE 50
541 THERAPEUTIC RESPONSE DECREASED 50
542 BLOOD PRESSURE SYSTOLIC INCREASED 49
543 COMPLICATION ASSOCIATED WITH DEVICE 49
544 DEVICE BREAKAGE 49
545 HAND FRACTURE 49
546 LIP SWELLING 49
547 MYASTHENIA GRAVIS CRISIS 49
548 MYOSITIS 49
549 CHRONIC LYMPHOCYTIC LEUKAEMIA 48
550 DEVICE OCCLUSION 48
551 EYE SWELLING 48
552 HEPATITIS 48
553 HYPOACUSIS 48
554 INJECTION SITE REACTION 48
555 ORAL INFECTION 48
556 PNEUMONIA FUNGAL 48
557 RASH PAPULAR 48
558 REBOUND EFFECT 48
559 TOOTHACHE 48
560 CARPAL TUNNEL SYNDROME 47
561 HEPATIC FUNCTION ABNORMAL 47
562 INJECTION SITE DISCHARGE 47
563 OSTEONECROSIS 47
564 OVERDOSE 47
565 TYPE 2 DIABETES MELLITUS 47
566 ANKLE FRACTURE 46
567 CHOLELITHIASIS 46
568 EATING DISORDER 46
569 FEEDING DISORDER 46
570 INFUSION SITE WARMTH 46
571 MALIGNANT NEOPLASM PROGRESSION 46
572 METABOLIC ACIDOSIS 46
573 OROPHARYNGEAL DISCOMFORT 46
574 POLLAKIURIA 46
575 SWOLLEN TONGUE 46
576 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 46
577 ANKLE ARTHROPLASTY 45
578 APHASIA 45
579 AUTOIMMUNE THYROIDITIS 45
580 BLOOD IMMUNOGLOBULIN G ABNORMAL 45
581 DEAFNESS 45
582 DEMENTIA 45
583 DISTURBANCE IN ATTENTION 45
584 FEAR OF INJECTION 45
585 FLATULENCE 45
586 KNEE ARTHROPLASTY 45
587 LIVER INJURY 45
588 LYMPHOPENIA 45
589 NERVE COMPRESSION 45
590 NIGHT SWEATS 45
591 RED BLOOD CELL COUNT DECREASED 45
592 SUSPECTED COVID-19 45
593 ABSCESS 44
594 APHONIA 44
595 BRONCHOPULMONARY ASPERGILLOSIS 44
596 CEREBRAL HAEMORRHAGE 44
597 COLITIS ULCERATIVE 44
598 DRUG-INDUCED LIVER INJURY 44
599 MEDICATION ERROR 44
600 THERAPY CESSATION 44
601 UROSEPSIS 44
602 BLADDER DISORDER 43
603 DEVICE RELATED INFECTION 43
604 ENCEPHALITIS AUTOIMMUNE 43
605 GALLBLADDER DISORDER 43
606 HYPOALBUMINAEMIA 43
607 INFUSION SITE DISCOLOURATION 43
608 MUSCULOSKELETAL CHEST PAIN 43
609 UNEVALUABLE EVENT 43
610 COLD SWEAT 42
611 COVID-19 IMMUNISATION 42
612 DEVICE DIFFICULT TO USE 42
613 FOETAL DEATH 42
614 GASTRIC INFECTION 42
615 INFUSION SITE INDURATION 42
616 PAIN IN JAW 42
617 PARANASAL SINUS DISCOMFORT 42
618 STATUS EPILEPTICUS 42
619 ACUTE RESPIRATORY DISTRESS SYNDROME 41
620 ADVERSE EVENT 41
621 BLOOD LACTIC ACID INCREASED 41
622 FULL BLOOD COUNT DECREASED 41
623 HAEMATOLOGICAL INFECTION 41
624 HALLUCINATION 41
625 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 41
626 PULMONARY OEDEMA 41
627 SINUSITIS BACTERIAL 41
628 SKIN IRRITATION 41
629 DRY THROAT 40
630 GASTROINTESTINAL TOXICITY 40
631 IMMUNOSUPPRESSION 40
632 MULTIPLE SCLEROSIS 40
633 PETECHIAE 40
634 PHARYNGEAL SWELLING 40
635 PNEUMONIA PSEUDOMONAL 40
636 PRESCRIBED OVERDOSE 40
637 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 40
638 SPINAL DISORDER 40
639 TOOTH FRACTURE 40
640 AGRANULOCYTOSIS 39
641 ANIMAL BITE 39
642 BLOOD URINE PRESENT 39
643 ENTEROCOCCAL INFECTION 39
644 GASTRITIS 39
645 GOUT 39
646 HEPATIC FAILURE 39
647 IMMUNE SYSTEM DISORDER 39
648 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 39
649 PULMONARY HYPERTENSION 39
650 PULMONARY TOXICITY 39
651 ACUTE HEPATIC FAILURE 38
652 ADENOVIRUS INFECTION 38
653 BLOOD CHOLESTEROL INCREASED 38
654 DRUG SPECIFIC ANTIBODY 38
655 HIATUS HERNIA 38
656 HORDEOLUM 38
657 HYPONATRAEMIA 38
658 MAST CELL ACTIVATION SYNDROME 38
659 OCULAR HYPERAEMIA 38
660 PNEUMONITIS 38
661 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 38
662 STIFF PERSON SYNDROME 38
663 BLOOD GLUCOSE DECREASED 37
664 CHROMATURIA 37
665 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 37
666 CRYING 37
667 ENCEPHALOPATHY 37
668 FLANK PAIN 37
669 HYPERTRANSAMINASAEMIA 37
670 KIDNEY TRANSPLANT REJECTION 37
671 PRODUCT LEAKAGE 37
672 RECTAL HAEMORRHAGE 37
673 SERUM FERRITIN INCREASED 37
674 SKIN REACTION 37
675 VASCULITIS 37
676 ALLERGIC SINUSITIS 36
677 ANTINUCLEAR ANTIBODY POSITIVE 36
678 ARTHRITIS INFECTIVE 36
679 ASPIRATION 36
680 BEDRIDDEN 36
681 DECREASED IMMUNE RESPONSIVENESS 36
682 EYE IRRITATION 36
683 FEMUR FRACTURE 36
684 INFECTED BITE 36
685 LUNG NEOPLASM MALIGNANT 36
686 PARTIAL SEIZURES 36
687 PLATELET COUNT ABNORMAL 36
688 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 36
689 SPUTUM PURULENT 36
690 TASTE DISORDER 36
691 URINARY INCONTINENCE 36
692 VENTRICULAR TACHYCARDIA 36
693 BLOOD PRESSURE DIASTOLIC DECREASED 35
694 EYE PRURITUS 35
695 FACIAL PAIN 35
696 HEPATIC CIRRHOSIS 35
697 INFUSION SITE OEDEMA 35
698 JOINT DISLOCATION 35
699 MENTAL IMPAIRMENT 35
700 RESTLESSNESS 35
701 SECONDARY IMMUNODEFICIENCY 35
702 BLOOD PRESSURE SYSTOLIC DECREASED 34
703 BRONCHOSPASM 34
704 CARDIOGENIC SHOCK 34
705 CARDIOMYOPATHY 34
706 DERMATITIS 34
707 DRUG EFFECT LESS THAN EXPECTED 34
708 ELECTROCARDIOGRAM QT PROLONGED 34
709 ELECTROLYTE IMBALANCE 34
710 FINE MOTOR SKILL DYSFUNCTION 34
711 FRUSTRATION TOLERANCE DECREASED 34
712 GLAUCOMA 34
713 HAEMORRHAGE INTRACRANIAL 34
714 HEPATIC STEATOSIS 34
715 KLEBSIELLA INFECTION 34
716 LACRIMATION INCREASED 34
717 MENISCUS INJURY 34
718 ORAL PAIN 34
719 PELVIC FRACTURE 34
720 RESTLESS LEGS SYNDROME 34
721 SECRETION DISCHARGE 34
722 VACCINATION FAILURE 34
723 BASAL CELL CARCINOMA 33
724 COOMBS DIRECT TEST POSITIVE 33
725 DEVICE MALFUNCTION 33
726 DYSURIA 33
727 HYPOTHYROIDISM 33
728 JAUNDICE 33
729 MOUTH ULCERATION 33
730 MYASTHENIC SYNDROME 33
731 NEOPLASM 33
732 NEOPLASM PROGRESSION 33
733 PNEUMONIA VIRAL 33
734 BODY TEMPERATURE DECREASED 32
735 BREAST MASS 32
736 CHRONIC KIDNEY DISEASE 32
737 DRUG ERUPTION 32
738 ELECTRIC SHOCK SENSATION 32
739 INJECTION SITE DISCOMFORT 32
740 INTERVERTEBRAL DISC DEGENERATION 32
741 OXYGEN SATURATION ABNORMAL 32
742 PERICARDITIS 32
743 PHOTOSENSITIVITY REACTION 32
744 POLYP 32
745 RECURRENT CANCER 32
746 THERMAL BURN 32
747 TRANSFUSION-RELATED ACUTE LUNG INJURY 32
748 VIRAL UPPER RESPIRATORY TRACT INFECTION 32
749 ACCIDENT 31
750 DISORIENTATION 31
751 DRUG DEPENDENCE 31
752 GRAFT VERSUS HOST DISEASE 31
753 HYPOPHOSPHATAEMIA 31
754 JOINT RANGE OF MOTION DECREASED 31
755 NON-HODGKIN^S LYMPHOMA 31
756 SHORT STATURE 31
757 SINUS HEADACHE 31
758 SKIN FISSURES 31
759 TRANSAMINASES INCREASED 31
760 VEIN RUPTURE 31
761 ANAPHYLACTIC SHOCK 30
762 ATYPICAL PNEUMONIA 30
763 DISSEMINATED INTRAVASCULAR COAGULATION 30
764 DYSKINESIA 30
765 EYE CONTUSION 30
766 GASTROINTESTINAL VIRAL INFECTION 30
767 HEART RATE ABNORMAL 30
768 HEPATITIS B 30
769 LOW BIRTH WEIGHT BABY 30
770 LYMPHADENITIS 30
771 MYOCARDITIS 30
772 PARANASAL SINUS HYPERSECRETION 30
773 POTENTIATING DRUG INTERACTION 30
774 SHOULDER FRACTURE 30
775 THERAPY CHANGE 30
776 CHOKING 29
777 GAMMA-GLUTAMYLTRANSFERASE INCREASED 29
778 INTENTIONAL DOSE OMISSION 29
779 LABORATORY TEST ABNORMAL 29
780 LYMPHOEDEMA 29
781 POLYNEUROPATHY 29
782 PRODUCT PRESCRIBING ERROR 29
783 SPINAL PAIN 29
784 ANAL INCONTINENCE 28
785 CUSHINGOID 28
786 EAR DISORDER 28
787 EMPHYSEMA 28
788 FAECES SOFT 28
789 GINGIVAL PAIN 28
790 HEMIPARESIS 28
791 HYPERAESTHESIA 28
792 INFUSION SITE NODULE 28
793 INJURY ASSOCIATED WITH DEVICE 28
794 NEPHROPATHY TOXIC 28
795 PROSTATE CANCER 28
796 PYELONEPHRITIS 28
797 SARS-COV-2 TEST POSITIVE 28
798 SPUTUM DISCOLOURED 28
799 STAPHYLOCOCCAL BACTERAEMIA 28
800 URINARY RETENTION 28
801 ABDOMINAL PAIN LOWER 27
802 ARTHROPOD STING 27
803 ATELECTASIS 27
804 AUTONOMIC NERVOUS SYSTEM IMBALANCE 27
805 BRAIN INJURY 27
806 BRAIN NEOPLASM 27
807 BRAIN OEDEMA 27
808 COLON CANCER 27
809 FEELING JITTERY 27
810 FOLLICULITIS 27
811 HEREDITARY ANGIOEDEMA 27
812 IMMUNOGLOBULINS ABNORMAL 27
813 INFECTIOUS MONONUCLEOSIS 27
814 LEUKOCYTOSIS 27
815 MALIGNANT MELANOMA 27
816 NERVE INJURY 27
817 PARAINFLUENZAE VIRUS INFECTION 27
818 PLEURISY 27
819 RENAL PAIN 27
820 TUMOUR MARKER INCREASED 27
821 VULVOVAGINAL PAIN 27
822 ABSCESS LIMB 26
823 ACUTE MYOCARDIAL INFARCTION 26
824 BK VIRUS INFECTION 26
825 BLOOD GLUCOSE ABNORMAL 26
826 BODY TEMPERATURE ABNORMAL 26
827 BONE DENSITY INCREASED 26
828 CIRCULATORY COLLAPSE 26
829 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 26
830 DISABILITY 26
831 DYSMENORRHOEA 26
832 DYSSTASIA 26
833 EMOTIONAL DISTRESS 26
834 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 26
835 EXTRA DOSE ADMINISTERED 26
836 FUNGAL SKIN INFECTION 26
837 GENE MUTATION 26
838 GENERALISED TONIC-CLONIC SEIZURE 26
839 GINGIVAL BLEEDING 26
840 GINGIVITIS 26
841 HAEMORRHOIDS 26
842 HERPES SIMPLEX 26
843 HIP ARTHROPLASTY 26
844 HYPOAESTHESIA ORAL 26
845 IMPAIRED QUALITY OF LIFE 26
846 INJECTION SITE IRRITATION 26
847 NICOTINE DEPENDENCE 26
848 OSTEOPENIA 26
849 PERIPHERAL COLDNESS 26
850 PRODUCT SUBSTITUTION ISSUE 26
851 RASH MACULO-PAPULAR 26
852 SPINAL OPERATION 26
853 SQUAMOUS CELL CARCINOMA 26
854 TENDONITIS 26
855 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 26
856 APPENDICITIS 25
857 BLOOD ALKALINE PHOSPHATASE INCREASED 25
858 BREAST DISORDER 25
859 CEREBRAL INFARCTION 25
860 CLOSTRIDIUM DIFFICILE COLITIS 25
861 COMPRESSION FRACTURE 25
862 CORONARY ARTERY ANEURYSM 25
863 DEATH OF RELATIVE 25
864 GASTRIC DISORDER 25
865 GASTROINTESTINAL INFLAMMATION 25
866 HEPATOMEGALY 25
867 LEFT VENTRICULAR DYSFUNCTION 25
868 MENTAL STATUS CHANGES 25
869 MUCOSAL INFLAMMATION 25
870 PARALYSIS 25
871 PARKINSON^S DISEASE 25
872 PYODERMA GANGRENOSUM 25
873 RAYNAUD^S PHENOMENON 25
874 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 25
875 SKIN MASS 25
876 SLUGGISHNESS 25
877 SMALL INTESTINAL OBSTRUCTION 25
878 ALLERGY TO CHEMICALS 24
879 ATRIOVENTRICULAR BLOCK 24
880 AUTISM SPECTRUM DISORDER 24
881 BLOOD BILIRUBIN INCREASED 24
882 BLOOD LACTATE DEHYDROGENASE INCREASED 24
883 CEREBRAL DISORDER 24
884 COELIAC DISEASE 24
885 DYSGEUSIA 24
886 GASTROENTERITIS 24
887 GRIP STRENGTH DECREASED 24
888 HEART RATE IRREGULAR 24
889 HYPOPROTEINAEMIA 24
890 INTERNAL HAEMORRHAGE 24
891 LIVER FUNCTION TEST INCREASED 24
892 MUSCLE ATROPHY 24
893 MUSCLE TIGHTNESS 24
894 PULMONARY CONGESTION 24
895 SMOOTH MUSCLE CELL NEOPLASM 24
896 CATHETER SITE PAIN 23
897 CREPITATIONS 23
898 CYANOSIS 23
899 DECUBITUS ULCER 23
900 DEPRESSED LEVEL OF CONSCIOUSNESS 23
901 DERMATITIS ALLERGIC 23
902 DISCHARGE 23
903 ENDOCARDITIS 23
904 FACE INJURY 23
905 HYPOGLYCAEMIA 23
906 INFUSION SITE INFECTION 23
907 INTRACRANIAL PRESSURE INCREASED 23
908 LIMB MASS 23
909 LIVE BIRTH 23
910 MALABSORPTION 23
911 MOOD SWINGS 23
912 PERIPHERAL VENOUS DISEASE 23
913 PROCEDURAL COMPLICATION 23
914 SENSITIVITY TO WEATHER CHANGE 23
915 TENDON RUPTURE 23
916 TRANSFUSION REACTION 23
917 ABDOMINAL INFECTION 22
918 ACNE 22
919 BREAST CANCER FEMALE 22
920 CARDIAC FAILURE CHRONIC 22
921 CEREBRAL VENOUS SINUS THROMBOSIS 22
922 DEVICE DISLOCATION 22
923 DUODENAL ULCER PERFORATION 22
924 ENERGY INCREASED 22
925 FACIAL PARALYSIS 22
926 HAND DERMATITIS 22
927 IMMUNOGLOBULINS INCREASED 22
928 ISCHAEMIC STROKE 22
929 JC VIRUS INFECTION 22
930 NORMAL NEWBORN 22
931 ORAL DISCOMFORT 22
932 PAPILLOEDEMA 22
933 PARONYCHIA 22
934 PSYCHOTIC DISORDER 22
935 SALMONELLOSIS 22
936 SARCOIDOSIS 22
937 SCOLIOSIS 22
938 SHOCK HAEMORRHAGIC 22
939 SINUS PAIN 22
940 SUICIDAL IDEATION 22
941 SUICIDE ATTEMPT 22
942 SYNOVIAL CYST 22
943 THERAPEUTIC RESPONSE UNEXPECTED 22
944 URINE OUTPUT DECREASED 22
945 ADRENAL DISORDER 21
946 ALLERGY TO PLANTS 21
947 AORTIC ANEURYSM 21
948 ARTHRITIS BACTERIAL 21
949 ATRIOVENTRICULAR BLOCK COMPLETE 21
950 CROUP INFECTIOUS 21
951 EHLERS-DANLOS SYNDROME 21
952 GLOMERULAR FILTRATION RATE DECREASED 21
953 HYPERTRIGLYCERIDAEMIA 21
954 INCREASED TENDENCY TO BRUISE 21
955 INJECTION SITE RASH 21
956 INTESTINAL PERFORATION 21
957 LUMBAR VERTEBRAL FRACTURE 21
958 LUNG INFILTRATION 21
959 LUPUS-LIKE SYNDROME 21
960 MACULAR DEGENERATION 21
961 MONOPLEGIA 21
962 MUSCLE TWITCHING 21
963 MYOPATHY 21
964 PLATELET COUNT INCREASED 21
965 POST PROCEDURAL HAEMORRHAGE 21
966 PRODUCT ADMINISTRATION INTERRUPTED 21
967 SCAB 21
968 STEVENS-JOHNSON SYNDROME 21
969 THYROID MASS 21
970 ABDOMINAL MASS 20
971 ATRIAL FLUTTER 20
972 BACTERIAL SEPSIS 20
973 BLINDNESS UNILATERAL 20
974 BLOOD PRESSURE SYSTOLIC ABNORMAL 20
975 FURUNCLE 20
976 GLUCOSE TOLERANCE IMPAIRED 20
977 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 20
978 HYPERGLYCAEMIA 20
979 HYPOMAGNESAEMIA 20
980 INTERMENSTRUAL BLEEDING 20
981 MALNUTRITION 20
982 MASTICATION DISORDER 20
983 MELAENA 20
984 MULTIPLE FRACTURES 20
985 MYELODYSPLASTIC SYNDROME 20
986 OESOPHAGEAL CANDIDIASIS 20
987 ORAL FUNGAL INFECTION 20
988 PNEUMONIA CYTOMEGALOVIRAL 20
989 PRODUCT PHYSICAL ISSUE 20
990 PRODUCT PREPARATION ISSUE 20
991 RENAL TRANSPLANT FAILURE 20
992 SKIN INJURY 20
993 SYMPTOM RECURRENCE 20
994 THROMBOCYTOPENIA NEONATAL 20
995 ANTIPHOSPHOLIPID SYNDROME 19
996 BLOOD CALCIUM INCREASED 19
997 BLOOD POTASSIUM INCREASED 19
998 BONE DISORDER 19
999 DENTAL CARIES 19